India’s Top Doctors & Industry Stalwarts to debate at historic 6th Annual Pharmaceutical Leadership Summit & Leadership Awards 2013

India’s Top Doctors & Industry Stalwarts to debate at historic 6th Annual Pharmaceutical Leadership Summit & Leadership Awards 2013

Dr Naresh Trehan, Dr NS Laud, Dr Mukesh Batra,Dr Shasank Joshi, Dr. G.S.K. Velu,Dr Chytra Anand, Dr Kaushal Pandey, Dr Harish Bhende, Dr Sudhir Vaishnav, Dr Jythydev Kesavadav,Dr Shuba Dharmana,Kewal Handa, Deepak Naik,Dr Hasit Joshipura among others to review the pulse of india healthcare sector

Wednesday,4th December 2013, Mumbai, Maharashtra, India : The state of the indian pharmaceutical & healthcare industry is definitely not in good shape as the nation has witnessed series of policy paralysis & the stand-off between the industry & the government. The latest blow to this is in in FDI in Pharma where the government has decided to continue with the existing policy on foreign direct investment in the pharmaceutical sector and not implement the revised policy proposed by the industry ministry. However, an additional condition has been imposed that in all cases of FDI in Brownfield pharma projects, there will be no non-compete clause in any of the inter se agreements. There is also a deep concern with regard to the image of the pharma industry in india due to the severe attack from the regulatory bodies such as US FDA. Pricing continues to be the challenging factor as majority of essential drugs are controlled by the pricing mechanism of the government. Healthcare insurance again is a concept in womb in india. The state of medical profession in india still needs to be improved given the huge requirements of doctors. It seems political priorities have overtaken Indian growth story.

Keeping in view the seriousness of the topic where the government has repeatedly failed to give a leadership direction & listen to the Indian drug makers coupled with the lack of a healthy dialogue between the doctors & the pharma companies, Pharmaleaders ( www.pharmaleaders.tv ), a division of Network 7 Media Group, is organizing its 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) at hotel hilton mumbai international airport on Friday 27th December 2013 in india under the theme Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda. Speaking to media on the Pharmaleaders 2013 annual meet, Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders said “ With the increasing pressure of the Indian pharmaceutical, Biotech Companies & Healthcare Firms to maintain the efficacy of the products & services in an era of price control, government regulation & international regulatory agencies to keep a alert on the companies to adhere to quality norms, the pharmaleaders forum attempt to bring a qualitative change in the minds of the pharmaleaders by bringing top leaders of the country in single plattform from the pharmaceutical, healthcare, biotechnology & medical profession to debate the significant issues grappling the country today. India’s branded formulation market has become fiercely competitive due to the pricing mechanism, regulatory challenges & FDI in Pharma sector” said  Satya Brahma.

Pharmaleaders has lined up top notch professionals to debate on wide array of subjects. Country’s top leaders in healthcare will debate to raise issues of far reaching consequences. Amongst the leaders who will address are Mr. Kewal Kanda,Promoter Director,Salus Lifecare Pvt Ltd on Decoding the success mantra of Indian Pharma Industry in an era of Govt regulations, Dr Mukesh Batra, Founder Chairman, Dr Batra’s Positive Health Clinic, on Challenges of Globalizing Homeopathic Medicines : A Dr Batra’s Case Study, Mr.Mahesh Zagade, Commissioner FDA, Maharashtra, Government of Maharashtra on Regulatory Challenges of Indian Plants. FDA Initiative to curb counterfeit drugs, Dr Shasank. R. Joshi ,Consulting Endocrinologist & Diabetologist on The Evolving Profile of the Indian Medical Practitioners : Doctors Expectations from the Pharmaceutical Companies – Beyond Gifts & Vacation Sponsorships, Mr. Deepak Naik,Managing Director, Health 'N' U Therapeutics Pvt. Ltd on Has the Pharmaceutical Companies failed to impress the doctors on medical education by adopting unethical means?, Dr.GSK Velu, Founder Chairman, Trivitron Group of Companies on Challenges & Oppourtunities of Indian Medical Device Industry, Dr Naresh Trehan, Cardiovascular and Cardiothoracic Surgeon & CMDS,Medanta on Making of India’s Leadership in Medical Innovation : The Real Time Experience, Dr. Shuba Dharmana,Cosmetic Dermatologist & Founder CEO, Le'jeune Medspa on The Changing Face of Indian Skincare Innovations, Prof. Dr. Nandkishore Shamrao Laud, Founder, Dr Laud Clinic on Cost effective Healthcare through citizens community participation.S. Krishnakumar of Future Steps will moderate the event.

Dr. Kaushal Pandey, Cardiac Surgeon, Dr. Sudhir Vaishnav, Interventional Cardiologist, Dr Deepak K Jhumani, Consultant in Sexual Health and Counsellor, Dr. Harish S. Bhende Orthopaedic Surgeon, Dr. Chytra v Anand, Founder&CEO & Chief Cosmetic Dermatologist, KOSMODERMA, Dr.Deepak Chaturvedi, Physician Endocrinologist & Dialectologist, Dr. Rashmi Shetty, Non-Surgical Aesthetic Medicine Expert will join in to a high voltage panel discussion on Ethics in Medical Profession. More than 250 Industry Leaders, Healthcare Experts, Pharma Academia, policy makers will be attending this historic summit.  

The healthcare sector in India will grow to $158.2 billion in 2017 from $78.6 billion in 2012, a report has said. "The healthcare sector is growing at a 15% CAGR and jumped from $45 billion in 2008 to $78.6 billion in 2012 and expected to touch $158.2 billion by 2017,The factors behind the growth is rising incomes, easier access to high-quality healthcare facilities and greater awareness of personal health and hygiene. The country's healthcare system is developing rapidly and it continues to expand its coverage, services and spending in both the public as well as private sectors. The private sector has emerged as a vibrant force in India's healthcare industry, lending it both national and international repute. Private sector's share in healthcare delivery is expected to increase from 66% in 2005 to 81% by 2015. Private sector's share in hospitals and hospital beds is estimated at 74% and 40%, respectively. There is substantial demand for high-quality and speciality healthcare services in tier-II and tier-III cities. To encourage the private sector to establish hospitals in these cities, government has relaxed the taxes on these hospitals for the first 5 years.Over the years, health insurance is gaining momentum in India; gross healthcare insurance premium is expanding at a CAGR of 39% over FY06-10. This trend is likely to continue, benefitting the country's healthcare industry.Strong mobile technology infrastructure and launch of 4G is expected to drive mobile health initiatives in the country. Mobile health industry in India is expected to reach $0.6 billion by 2017.To standardize the quality of service delivery, control cost and enhance patient engagement, healthcare providers are focussing on the technological aspect of healthcare delivery.Digital health knowledge resources, electronic medical record, mobile healthcare, hospital information system are some of the technologies gaining acceptance in the sector. Going forward, the healthcare sector's spending on IT products and services is expected to rise from $53 billion in 2012 to $57 billion in 2013.

The 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards will also felicitate top performers in 30 award categories besides individual recognition from the jury members to the ambassadors of Indian healthcare industry.